RxDoctor Payments Data

Sheena Hoadley

Family · Springfield, ILNPI 1467042507

Payments from drug & device makers

$10,111in general payments, 2019–2025

Across 72 payments — averaging $140.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Abbott$4K
  • Boston Scientific$2K
  • Kerecis Limited$183
  • MDD US Operations, LLC$87
  • Acadia Pharmaceuticals Inc$59
  • plus $101 from 2 others

What the payments were for

  • Speaking & faculty fees$511%
  • Travel & lodging$7,53174%
  • Food & beverage$2,39324%
  • Education$1351%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,111 in reported general payments places this provider in the 95th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$31,269
Medicare patients
185
Services billed
464

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RytaryCarbidopa/Levodopa186$233,919
GocovriAmantadine Hcl26$65,813
Carbidopa-LevodopaCarbidopa/Levodopa725$17,758
Carbidopa-Levodopa ErCarbidopa/Levodopa230$12,239
AmantadineAmantadine Hcl151$6,407
Rasagiline Mesylate47$5,590
Selegiline Hcl79$4,814
Clonazepam213$1,659
Ropinirole Hcl68$1,493
Donepezil Hcl193$1,487
Pregabalin35$1,438
Quetiapine Fumarate63$1,216
Propranolol Hcl64$904
Pramipexole DihydrochloridePramipexole Di-Hcl117$827
Propranolol Hcl ErPropranolol Hcl31$733

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Amneal Pharmaceuticals LLCRytary$51$233,919186 claims
MDD US Operations, LLCGocovri$87$65,81326 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,941 family providers in Illinois.

Other family in Springfield

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →